Sevoflurane 100% inhalation vapour liquid
NHS hospitals in England used £23,652,752 of indicative cost of Sevoflurane 100% inhalation vapour liquid in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 2.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Sevoflurane 100% inhalation vapour liquid: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Sevoflurane 100% inhalation vapour liquid most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Leeds Teaching Hpls Nhs Trust | £690,153 |
| Univ Hpl B/Ham Nhs Foundation Trust | £626,931 |
| Barts Health Nhs Trust | £564,816 |
| Manchester University Nhs Ft | £471,951 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £448,704 |
| Guy's & St Thomas' Nhs Foundation Trust | £424,842 |
| University Hpls Of Leicester Nhs Trust | £410,820 |
| King's College Hpl Nhs Foundation Trust | £388,557 |
| Southend Univ Hosp Nhs Foundation Trust | £382,161 |
| University Hpls North Midlands Nhs Trust | £377,856 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.